Karen Dybkaer Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

11/2020	XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.
2/2015	Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen Dybkaer Research Topics

Disease

18	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2022 - 11/2012
13	Neoplasms (Cancer) 01/2020 - 08/2009
6	Lymphoma (Lymphomas) 01/2021 - 06/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2020 - 02/2015
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 05/2015
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2013 - 02/2010
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2013 - 02/2010
2	Multiple Myeloma 01/2013 - 04/2011
2	Influenza in Birds (Avian Flu) 01/2004 - 01/2003
1	Papillomavirus Infections 10/2017
1	Spontaneous Abortion (Miscarriage) 10/2017
1	Premature Obstetric Labor (Premature Labor) 10/2017
1	Disease Progression 03/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2015
1	B-Cell Leukemia (Leukemia, B Cell) 06/2014
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2010
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2010
1	Hematologic Neoplasms (Hematological Malignancy) 07/2010
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2010

Drug/Important Bio-Agent (IBA)

12	Rituximab (Mabthera)FDA Link 01/2020 - 11/2012
5	Proteins (Proteins, Gene)FDA Link 12/2015 - 08/2009
4	Biological ProductsIBA 01/2022 - 03/2015
4	MicroRNAs (MicroRNA)IBA 06/2015 - 09/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016 - 11/2012
3	Prednisone (Sone)FDA LinkGeneric 12/2016 - 11/2012
3	Vincristine (Oncovin)FDA LinkGeneric 12/2016 - 11/2012
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 10/2017
2	Anaplastic Lymphoma KinaseIBA 09/2013 - 02/2010
2	3' Untranslated Regions (3' UTR)IBA 05/2013 - 08/2009
2	Melphalan (Alkeran)FDA LinkGeneric 01/2013 - 04/2011
2	Pharmaceutical PreparationsIBA 01/2013 - 04/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2004 - 01/2003
1	RNA (Ribonucleic Acid)IBA 03/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	selinexorIBA 11/2020
1	Drug CombinationsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	IgKIBA 10/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016
1	AntigensIBA 12/2016
1	NF-kappa B (NF-kB)IBA 12/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2015
1	Chemokine ReceptorsIBA 03/2015
1	Cyclin D1IBA 06/2014
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2014
1	NucleotidesIBA 05/2013
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2010
1	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2010
1	CatalaseIBA 07/2010
1	NucleoproteinsIBA 01/2004
1	avian influenza A virus hemagglutininIBA 01/2004
1	ImmunosorbentsIBA 01/2003
1	EnzymesIBA 01/2003

Therapy/Procedure

7	Therapeutics 01/2018 - 06/2004
1	Radiotherapy 07/2014
1	Drug Therapy (Chemotherapy) 04/2011